Through debra of America’s advocacy work, Epidermolysis Bullosa (EB) has made it on the list of eligible diseases for research funding through the U.S. Department of Defense’s Congressionally Directed Medical Research Program (CDMRP).
The CDMRP includes a Peer Review Panel that consists of Consumer Reviewers (patients, family members, caregivers or health care providers) and scientists. This panel is critically important in evaluating research applications to ensure that the research is relevant and has the potential to make a substantial impact on the community.